Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Coronary artery diagnostic to enter clinical studies

April 5, 1996

Alzheimer's diagnostics introduced in U.S.

April 5, 1996

Molecular Biosystems, Shionogi agreement on the rocks

April 5, 1996

Ostex's NTx assay highly sensitive, specific in detecting bone turnover

April 5, 1996

Molecular Biosystems presents preliminary FS069 study results

April 5, 1996

Axcan to distribute Helisal in Canada

April 5, 1996

RIGScan CR49 clinical data presented

April 5, 1996

Sonus completes enrollment in EchoGen trial

March 15, 1996

FDA approves HIV screening kit

March 15, 1996

Patent issued on technology for detecting susceptibility to cancer

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.